1 |
35411950 |
10.1002/cbf.3702 |
2022 |
USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. |
PRKCB |
2 |
32779615 |
10.3960/jslrt.20019 |
2021 |
Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma. |
PRKCB |
3 |
33098696 |
10.1111/ejh.13540 |
2021 |
RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma. |
PRKCB |
4 |
33241658 |
10.1111/jcmm.16117 |
2021 |
Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin. |
PRKCB |
5 |
33426772 |
10.1111/cas.14806 |
2021 |
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains. |
PRKCB |
6 |
31757376 |
10.1016/j.jtho.2019.07.021 |
2020 |
Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib. |
PRKCB |
7 |
31883669 |
10.1016/j.pathol.2019.09.014 |
2020 |
The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma. |
PRKCB |
8 |
31961925 |
10.1182/blood.2019001815 |
2020 |
Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions. |
PRKCB |
9 |
29084771 |
10.1182/blood-2017-01-761874 |
2019 |
Prognostic relevance of integrated genetic profiling in adult T-cell leukemia/lymphoma. |
PRKCB |
10 |
30097855 |
10.1007/s10689-018-0099-x |
2019 |
Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma. |
PRKCB |
11 |
31035338 |
10.3390/ijms20092089 |
2019 |
Marek's Disease Virus Regulates the Ubiquitylome of Chicken CD4<sup>+</sup> T Cells to Promote Tumorigenesis. |
PRKCB |
12 |
27835906 |
10.18632/oncotarget.13239 |
2018 |
Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma. |
PRKCB |
13 |
28246354 |
10.1042/BSR20160445 |
2018 |
Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin. |
PRKCB |
14 |
28115366 |
10.1182/blood-2016-09-692574 |
2017 |
Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells. |
PRKCB |
15 |
28369050 |
10.1038/ni.3716 |
2017 |
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. |
PRKCB |
16 |
28627735 |
10.1111/cas.13303 |
2017 |
Genetic alterations in adult T-cell leukemia/lymphoma. |
PRKCB |
17 |
28694326 |
10.1182/blood-2017-02-768234 |
2017 |
Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E). |
PRKCB |
18 |
25693686 |
10.1093/abbs/gmv003 |
2016 |
Effects of azidothymidine on protein kinase C activity and expression in erythroleukemic cell K562 and acute lymphoblastic leukemia cell HSB-2. |
PRKCB |
19 |
26437031 |
10.1038/ng.3415 |
2016 |
Integrated molecular analysis of adult T cell leukemia/lymphoma. |
PRKCB |
20 |
26462016 |
10.18632/oncotarget.5462 |
2016 |
Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo. |
PRKCB |
21 |
27169444 |
10.11406/rinketsu.57.417 |
2016 |
[Genetic landscape of adult T-cell leukemia/lymphoma]. |
PRKCB |
22 |
25502755 |
10.1038/ncomms6719 |
2015 |
An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins. |
PRKCB |
23 |
25548371 |
10.1093/jmcb/mju050 |
2015 |
Protein kinase C-δ and -β coordinate flow-induced directionality and deformation of migratory human blood T-lymphocytes. |
PRKCB |
24 |
26121314 |
10.1038/labinvest.2015.83 |
2015 |
Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing. |
PRKCB |
25 |
21997316 |
10.2310/JIM.0b013e318237eb55 |
2013 |
Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells. |
PRKCB |
26 |
23328482 |
10.1016/j.ccr.2012.12.003 |
2013 |
Protein kinase c-β-dependent activation of NF-κB in stromal cells is indispensable for the survival of chronic lymphocytic leukemia B cells in vivo. |
PRKCB |
27 |
23861246 |
10.1182/blood-2013-01-478156 |
2013 |
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia. |
PRKCB |
28 |
20439192 |
10.3816/CLC.2010.n.021 |
2010 |
Protein kinase C-beta gene variants, pathway activation, and enzastaurin activity in lung cancer. |
PRKCB |
29 |
20846475 |
|
2010 |
Specific inhibition of protein kinase Cbeta expression by antisense RNA affects the activation of Jurkat T lymphoma cells. |
PRKCB |
30 |
17926183 |
10.1080/10428190701636443 |
2008 |
Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. |
PRKCB |
31 |
15090600 |
10.1242/jcs.00955 |
2005 |
Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton. |
PRKCB |
32 |
14699138 |
10.1074/jbc.M306672200 |
2004 |
Ki-1/57 interacts with RACK1 and is a substrate for the phosphorylation by phorbol 12-myristate 13-acetate-activated protein kinase C. |
PRKCB |
33 |
12730099 |
10.1182/blood-2002-11-3621 |
2003 |
Integration of DAG signaling systems mediated by PKC-dependent phosphorylation of RasGRP3. |
PRKCB |
34 |
12118249 |
10.1038/ni823 |
2002 |
PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. |
PRKCB |
35 |
10641798 |
10.1016/s1357-2725(99)00097-7 |
2000 |
HIV-1 reverse transcriptase is phosphorylated in vitro and in a cellular system. |
PRKCB |
36 |
10212259 |
10.1074/jbc.274.18.12753 |
1999 |
Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation. |
PRKCB |